Data Driven Quantification
Our results are quantified from TRANSACTIONAL DATA. Through the implementation of intelligent systems, we know the value difference between unmanaged patients and those whose adherence is managed. The return on your investment is based on fact.
Large Patient Numbers
We are able to engage high volumes of patients through our pharmacy relationships. We have seen over 10 million people visit our pharmacy partners over the last five-year period. High adherence gains are amplified by the high enrolment figures, resulting in visible sales growth. Adherence of 1 000 patients is not significant. However, the enrolment of 20 000 patients and the substantial improvement of their adherence has great impact.
A 10% adherence gain does not sound exciting. However, being able to retain almost double the patients over a 12-month period, is. This is one of the reasons why multinationals regard Health Window’s adherence services as the best on the globe.
The Health Window intelligent management systems allow for patient management costs to be apportioned to pharma and pharmacy. This cost model allows us to deliver the most cost-effective interventions in the industry.
Real World Outcomes
In the real world, non-adherence to therapy detracts from optimal outcomes and this is why we cannot rely on clinical trial result in a ‘real-world’ setting. The gap between clinical trial results and real-world efficacy can be bridged through the implementation of programmes that improve patient adherence.
A doctor is more likely to switch a patient’s medication due to sub-optimal results (although caused by the patient’s non-adherence). Therefore, if a patient is adherent, doctors are less likely to switch patients to other drugs.